EUCTR2015-002699-26-DE进行中（未招募）不适用
Pilot study of tolerability and effectivity following application of two combination topical acne products clindamycin 1% and 0.025% tretinoin gel (Acnatac® Gel), adapalen 0,1% and benzoyl peroxide 2,5% gel (Epiduo® Gel).
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- GWT-TUD GmbH
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Diagnosis of mild to moderate facial acne vulgaris at baseline- Age: 14 years to 50 years
- •- No evidence of facial irritation (erythema, dryness/scaling,
- •burning/itching/stinging) that is not typical for acne vulgaris
- •-Willingness to take part in acne study including screening visit and follow up visits on day 0,7, and 21
- •-No use of systemic antibiotics, steroids, retinoids and keratolytics within the last 30 days before start of the acne study
- •-Patients have to sign personally consent form and follow study procedures
- •-Patient is in good general health
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Female patients who were pregnant, planning to become pregnant or breastfeeding
- •-Sexually active female subjects do not use a medically acceptable form of contraception (oral contraception, injectable or implantable methods or intrauterine devices)
- •- Female patients who are in childbreaking years except
- •post-menopausal (12 Monate natürliche Amenorrhoe),
- •? postoperative (6 weeks after ovariectomy with or without hysterectomy)
- •-regulary and correct use of contraceptive with error rate < 1 %/year
- •- vasectomy of the partner
- •- Diseases of the facial skin other than acne
- •-No concomitant topical medications (including make-up) or keratolytics as sulphur, salicylic acid, benzoyl peroxide, resorcin and abradents and acid-containing peels one week before the study starts
- •-Patients who had facial procedures (chemical peel, laser therapy, photodynamic therapy, microdermabrasion, or UV light therapy) within the past 4 weeks
- •-No concomitant participation in other studies within the past 30 days
- •-Hypersensitivity against any ingredients of Acnatac® -gel or Epiduo®gel
- •-Systemic medication with antibiotics or antibiotics within the last 4 weeks before study start
- •- Systemic medication with retinoids within the last 6 months before study start
- •-Topical treatment of acne vulgaris within the last two weeks before study
- •-Acne fulminans,
- •-Severe systemic disease respectively taking immunosuppressive drugs
- •-Severe liver disease
- •-Severe renal disease
- •-History or presence of regional enteritis or inflammatory bowel disease
- •-Other reasons that the doctor in charge decides about
研究者
相似试验
已完成
不适用
A pilot study to assess the tolerability and the effectiveness of combination treatment of olanzapine and escitalpram for bipolar depression in Japamajor depressive episode of bipolar disorderJPRN-UMIN000014204Department of Psychiatry, Hokkaido University Hospital60
已完成
2 期
A pilot study to explore the tolerability and efficacy of bortezomib as part of induction and post-transplant therapy in multiple myelomaMultiple myelomaACTRN12605000770662Clinical Haematology & Bone Marrow Transplant Unit, Royal Adelaide Hospital60
招募中
2 期
A pilot study comparing the efficacy of artesunate alone and artesunate plus azithromycin for the treatment of Plasmodium falciparum malaria in central VietnamMalaria infectionInfection - Other infectious diseasesACTRN12610000546055Australian Army Malaria Institute60
进行中（未招募）
不适用
Pilotstudie zur Verträglichkeit und Effektivität eines Artischockenpräparates bei Patienten mit chronischer Hepatitis CEUCTR2005-000687-77-DEni-Zentrum naturheilkunde16
已完成
不适用
Repeat prostate evaluation and therapy pilot study in patients undergoing high dose rate brachytherapy for prostate cancerCancer - ProstateProstate CancerACTRN12610001076066Peter MacCallum Cancer Centre13